New cannabidiol (CBD) derivatives: Synthesis, anti-inflammatory activity, and molecular docking

Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells

(2022) Hideki Kitaura et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review

(2021) Alessia Furgiuele et al.   Journal of Neuroimmune Pharmacology

Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence

(2020) Cinzia Citti et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Synthesis of (-)-epigallocatechin-3-gallate derivative containing a triazole ring and combined with cisplatin/paclitaxel inhibits NSCLC cancer cells by decreasing phosphorylation of the EGFR

(2020) Cheng-Ting Zi et al.   JOURNAL OF CHEMICAL RESEARCH

Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts

(2020) Torsten Lowin et al.   Cell Death & Disease

DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor

(2019) Rangel L. Silva et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Cannabidiol Adverse Effects and Toxicity

(2019) Marilyn A. Huestis et al.   Current Neuropharmacology

Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog

(2019) Cinzia Citti et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history

(2018) Sara Anna Bonini et al.   JOURNAL OF ETHNOPHARMACOLOGY

Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells

(2018) David M. Elliott et al.   Frontiers in Immunology

Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage

(2018) Lorena Barata et al.   NEUROPHARMACOLOGY

Cannabis cultivation: Methodological issues for obtaining medical-grade product

(2017) Suman Chandra et al.   EPILEPSY & BEHAVIOR

Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders

(2017) Alline C. Campos et al.   Frontiers in Pharmacology

Caffeine prevents LPS-induced inflammatory responses in RAW264.7 cells and zebrafish

(2016) Ji-Hyun Hwang et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Recent progress in the enzymatic glycosylation of phenolic compounds

(2016) Lijuan Xu et al.   JOURNAL OF CARBOHYDRATE CHEMISTRY

D(−)-Salicin inhibits the LPS-induced inflammation in RAW264.7 cells and mouse models

(2015) Yang Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Neuroinflammation in Alzheimer's disease

(2015) Michael T Heneka et al.   LANCET NEUROLOGY

CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency

(2015) Reem Smoum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Substituent Effects on in Vitro Antioxidizing Properties, Stability, and Solubility in Flavonoids

(2014) Merichel Plaza et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities

(2013) I. Tabas et al.   SCIENCE

Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death

(2013) N Rimmerman et al.   Cell Death & Disease

The cationic amphiphile 3,4-bis(tetradecyloxy)benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding

(2010) Matteo Piazza et al.   BIOCHEMICAL PHARMACOLOGY

Differential inflammatory responses in aging and disease: TNF-α and IL-6 as possible biomarkers

(2010) David de Gonzalo-Calvo et al.   FREE RADICAL BIOLOGY AND MEDICINE

Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes

(2010) Susana Mato et al.   GLIA

Enzymatically Modified Isoquercitrin, α-Oligoglucosyl Quercetin 3-O-Glucoside, Is Absorbed More Easily than Other Quercetin Glycosides or Aglycone after Oral Administration in Rats

(2009) Toshiaki Makino et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

12/15-Lipoxygenase Is Required for the Early Onset of High Fat Diet-Induced Adipose Tissue Inflammation and Insulin Resistance in Mice

(2009) Dorothy D. Sears et al.   PLoS One

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

(2007) A Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY